What is Melanotan II?
Melanotan II is a synthetic peptide closely related to Melanotan I, but with broader activity across melanocortin receptors. Initially investigated for its tanning effects, Melanotan II became widely known for its additional influence on appetite suppression and sexual arousal. Unlike afamelanotide, Melanotan II is not an approved medication and is considered an unregulated research compound.
In the research setting, the tanning effect of Melanotan II is critical, as it results in tanning without causing the negative effects of UV light, which is the most important cause of skin cancer.
How Does Melanotan II Work?
Melanotan II activates multiple melanocortin receptors, including MC1R (pigmentation), MC3R, and MC4R (central nervous system regulation of appetite and sexual function). This non-selective receptor activation explains its wide range of effects.
Stimulation of MC1R increases melanin production, leading to darker skin pigmentation. Activation of MC4R in the brain can suppress appetite and trigger sexual arousal, effects that are not present with Melanotan I.
What is Melanotan II Used for?
Potential research applications for Melanotan II include:
- Cosmetic tanning without UV exposure
- Appetite suppression
- Libido enhancement
Side Effects of Melanotan II
Side effects may include nausea, flushing, fatigue, spontaneous erections, appetite loss, and darkening of moles. There have been case reports of more serious complications, including prolonged erections and concerning skin changes.
Melanotan II Dosing Protocol (for Research)
Melanotan II research dosing protocols call for administration under the skin (subcutaneous). While there are no established dosage recommendations, the research dosing protocol commonly discussed is the following:
| Phase | Dose & frequency |
|---|---|
| Weeks 1-2 (loading phase) | 0.5 mg/day |
| Week 3 and beyond (maintenance phase) | 0.25 mg/day |
Shown for education. A licensed clinician should set any actual dose. Compare protocols across peptides in the peptide dosage chart.
Common questions about Melanotan II
What is Melanotan II?
Melanotan II is a synthetic peptide closely related to Melanotan I, but with broader activity across melanocortin receptors. Initially investigated for its tanning effects, Melanotan II became widely known for its additional influence on appetite suppression and sexual arousal.
What is Melanotan II used for?
Areas studied include: Cosmetic tanning without UV exposure; Appetite suppression; Libido enhancement.
How does Melanotan II work?
Melanotan II activates multiple melanocortin receptors, including MC1R (pigmentation), MC3R, and MC4R (central nervous system regulation of appetite and sexual function). This non-selective receptor activation explains its wide range of effects.
What are the side effects of Melanotan II?
Side effects may include nausea, flushing, fatigue, spontaneous erections, appetite loss, and darkening of moles. There have been case reports of more serious complications, including prolonged erections and concerning skin changes.
What is the dosage of Melanotan II?
One commonly referenced research protocol is: Weeks 1-2 (loading phase): 0.5 mg/day; Week 3 and beyond (maintenance phase): 0.25 mg/day. Shown for education only; a licensed clinician should set any actual dose. See the dosing table.
How do you mix (reconstitute) Melanotan II?
Wipe the vial tops with alcohol, add bacteriostatic water slowly so it runs down the inside of the glass, then roll the vial gently until the powder dissolves; don’t shake it. See the step-by-step guide with diagrams for the pen and syringe methods.
How much bacteriostatic water do you add to Melanotan II?
There is no single correct amount. We recommend 2.1 mL: about 0.1 mL is lost during transfer, leaving roughly 2.0 mL of usable solution. You can add more or less (most peptide vials hold up to 3 mL); just enter the amount in the dose calculator. See the step-by-step mixing guide.
Is Melanotan II FDA-approved?
No. Melanotan II is not FDA-approved in the US (status as of October 2026).
References
- Tsatmali M, et al. Melanocyte function and its control by melanocortin peptides. J Histochem Cytochem. 2002;50:125-33. doi: 10.1177/002215540205000201. View source
- Glavas MM, et al. Melanocortinergic activation by melanotan II inhibits feeding and increases uncoupling protein 1 messenger ribonucleic acid in the developing rat. Endocrinology. 2007;148:3279-87. doi: 10.1210/en.2007-0184. View source